Based on the INEAST biosensing results toward the four cfDNA biomarkers as shown in Figure 5b–e, we confirmed that the overall expression levels of EGFR, TP53, and PTEN were higher in the lung cancer group compared to the control group as shown in Figure 5b–d. This evidence concerns the gene EGFR and lung carcinoma.